S.Africa seals record deal for low-cost ARVs: minister

November 29, 2012

South Africa, home to the world's largest population of people living with HIV, said Thursday it had secured a deal to buy a key anti-retroviral (ARV) drug at the lowest price ever.

The country is the world's largest consumer of the life-saving drugs, at 21 percent of the world market.

Aaron Motsoaledi announced the country had used this massive market share to negotiate a record-low price on a three-in-one, fixed-dose .

The once-a-day tablet will cost patients 89.37 rand a month ($10, eight euros), the minister said.

"This is now the world's lowest price for this product," he said.

"In pursuit of and using innovative methods we have been able to (achieve) a massive saving."

Motsoaledi said the government had awarded a two-year, 5.9-billion-rand ($671-million, 517-million-euro) tender to three for the drug, down from an original cost of 8.1 billion rand.

Aspen Pharmacare, Cipla Medpro and Mylan pharmaceuticals are the three companies that won the tender.

The government plans to expand the treatment to reach 2.5 million people in the next two years. Patients have been taking three pills a day, but the new regimen reduces them to one and the combination has fewer side effects.

South Africa once refused to roll out ARVs under former president Thabo Mbeki, whom activists have condemned as an "AIDS denialist". But the country now has the largest anti-retroviral (ARV) programme in the world, serving 1.7 million of its 5.6 million HIV-positive people.

Demographers reported recently that life expectancy in South Africa had shot up by six years to 60 over the past few years thanks to ARV treatment.

The country has one of the world's highest , at 17.8 percent of 15- to 49-year-olds.

Doctors Without Borders (MSF) praised the deal, saying the government had used its negotiating power to buy the fixed-dose combinations at "extremely competitive prices".

Patients "now finally have access to simpler and improved treatment options—which significantly cuts down their daily pill burden from three to five pills down to just one," said Gilles Van Cutsem, the aid group's medical coordinator in South Africa.

Explore further: South Africa reports new success in saving newborns from HIV

Related Stories

South Africa reports new success in saving newborns from HIV

July 19, 2012
About 117,000 babies were saved from HIV infection last year under South Africa's scheme to prevent mothers from passing on the disease during childbirth, health official said Thursday.

South Africa unveils plan to halve HIV infections

December 1, 2011
President Jacob Zuma on Thursday unveiled a plan to halve the number of HIV infections over the next five years, cementing South Africa's turnaround from years of deadly denialism.

Mozambique launches Brazil-funded drugs plant to battle HIV

July 21, 2012
Mozambique on Saturday launched a Brazilian funded pharmaceutical plant that will make anti-retroviral drugs to battle the HIV/AIDS scourge in the southern African country.

S.Africa in $208 mln AIDS drug venture with Swiss Lonza

February 10, 2012
South Africa on Friday unveiled plans for a 1.6 billion rand ($208 million, 157 million euro) pharmaceutical plant, in a joint venture with Swiss biochemicals group Lonza to produce anti-AIDS drugs.

Sanofi teams up with India to make cheap ARVs in S.Africa

March 30, 2012
French pharmaceutical giant Sanofi has signed a partnership with India's Hetero to manufacture cheap anti-HIV drugs in South Africa, the company said on Friday.

Recommended for you

HIV-1 genetic diversity is higher in vaginal tract than in blood during early infection

January 18, 2018
A first-of-its-kind study has found that the genetic diversity of human immunodeficiency virus type 1 (HIV-1) is higher in the vaginal tract than in the blood stream during early infection. This finding, published in PLOS ...

War in Ukraine has escalated HIV spread in the country: study

January 15, 2018
Conflict in Ukraine has increased the risk of HIV outbreaks throughout the country as displaced HIV-infected people move from war-affected regions to areas with higher risk of transmission, according to analysis by scientists.

Researchers offer new model for uncovering true HIV mortality rates in Zambia

January 12, 2018
A new study that seeks to better ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches, and ultimately, more effective HIV treatment strategies.

New drug capsule may allow weekly HIV treatment

January 9, 2018
Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule ...

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

January 8, 2018
A team of Yale researchers tested a new chemical compound that suppresses HIV, protects immune cells, and remains effective for weeks with a single dose. In animal experiments, the compound proved to be a promising new candidate ...

Usage remains low for pill that can prevent HIV infection

January 8, 2018
From gritty neighborhoods in New York and Los Angeles to clinics in Kenya and Brazil, health workers are trying to popularize a pill that has proven highly effective in preventing HIV but which—in their view—remains woefully ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.